Where does Alcresta Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alcresta Therapeutics, Inc. ranks #13,291 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alcresta Therapeutics, Inc. hold?

Alcresta Therapeutics, Inc. holds 22 US utility patents granted between 2017 and 2024, spanning 12 technology areas.

What is Alcresta Therapeutics, Inc.'s Innovation Score?

Alcresta Therapeutics, Inc. has an Innovation Score of 47.4 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Alcresta Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Alcresta Therapeutics, Inc.'s recent grant velocity is +240% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Alcresta Therapeutics, Inc.'s patents?

Alcresta Therapeutics, Inc.'s patents average 23.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alcresta Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Alcresta Therapeutics, Inc.

Q: What technology areas does Alcresta Therapeutics, Inc. focus on?

Alcresta Therapeutics, Inc.'s top technology area is A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof) with 20 patents. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 22 granted patents across 12 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alcresta ranks #13,291 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 12 technology areas.

#13,291
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.4/100): 23.1
avg claims per patent: +240%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13291 · US Corporation #13,291 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,291/49,997
PHOTO-FINISH ACell
CPC-FOCUS A23L · 12 areas
INNOV-PAR 47.4/100
CLAIMS-DENSE 23.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +240% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ACell, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Alcresta Therapeutics · this assignee

47
3D Lighting… · lowest

7

What this shows Alcresta's Innovation Score is 47.4/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Alcresta's grants concentrate

Alcresta Therapeutics, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 90.9% of grants classified under A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof). Peak complete grant year is 2024 (9 grants) versus a trough of 1 in 2019. By volume, Alcresta sits between ACell, Inc. and Andes Technology Corporation.

Alcresta's three-year grant acceleration

Alcresta Therapeutics, Inc. shows 11 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Acell

22
ADC Therapeutics

22
Advanpack Solutio…

22
Albany Molecular…

22
Alcyone Lifescien…

22
American Maid Pla…

22
Amerlux

22
Andes Technology

22
Alcresta Therapeu… ◀

22

What this shows Alcresta holds 22 patents at rank #13,282, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alcresta

By rank, the assignees closest to #13,282 in granted patent volume.

Leaders in A23L (Foods)

Other assignees with the most granted patents in Alcresta's primary technology class.

Alcresta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Alcresta Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	4	18.2%
2019	1	4.5%
2020	3	13.6%
2021	3	13.6%
2022	2	9.1%
2024	9	40.9%

Which technologies does Alcresta Therapeutics, Inc. patent most?

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 20

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 20

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

C12Y - Enzymes 14

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 12

A23D - Edible Oils OR Fats, e.g. Margarines, Shortenings OR Cooking Oils 12

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A23K - Fodder 12

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 12

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#13,291

of 49,997 tracked assignees

Innovation Score

47.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Alcresta Therapeutics, Inc.'s patent record in context - here's where to go next.

Alcresta Therapeutics, Inc.'s lead technology class is A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof), 90.9% of its portfolio - see every assignee active in that class. Explore A23L
Ranked #13,291 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alcresta Therapeutics, Inc. against ACell, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.